Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

takeda_usa_pharmaceuticals_u

Takeda’s Ninlaro combo fails to hit main goal in newly diagnosed, transplant ineligible multiple myeloma

March 11, 2020 Research and Development, Sales and Marketing Ninlaro, Takeda, multiple myeloma, pharma

Takeda has unveiled new Phase 3 data for its oral proteasome inhibitor Ninlaro (ixazomib) in the treatment of newly diagnosed …
News

A man from London becomes second person to be cured of HIV

March 11, 2020 Research and Development HIV, HIV AIDS, HIV Drug, HIV cure, HIV/AIDS, anti-HIV

Adam Castillejo is the second man to be cured of HIV, after being free of the virus for more than …
News
mitchell_web

Data science firm Genomics Plc names new Chief Strategy Officer

March 10, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing genomics, pharma

Data science firm Genomics Plc, which lays claim to “the world’s largest genomic database”, has welcomed Mitchell Harris to the …
Appointment
conference_peach

The American Academy of Allergy, Asthma and Immunology calls off its 2020 Annual Meeting due to coronavirus concerns

March 10, 2020 Medical Communications, Research and Development Big Pharma, allergy, america, asthma, immunology

The American Academy of Allergy, Asthma and Immunology (AAAAI) has called off its 2020 Annual Meeting that was schedule to …
News
medium_ab

Alligator Bioscience hires Chief Financial Officer in interim capacity

March 9, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alligator Bioscience, pharma

Andreas Johannesson has been announced as Alligator Bioscience’s new interim Chief Financial Officer (CFO), replacing ex-CFO Per-Olof Schrewelius who it …
Appointment
lars_nieba-web-image_0

Dr Lars Nieba appointed interim Chief Executive Officer at Nordic Nanovector

March 9, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Nordic Nanovector has appointed Dr Lars Nieba as the interim Chief Executive Officer. He is currently the company’s Chief Technology …
Appointment
chris-thatcher-headshot_750xx1602-2136-155-0_1

Chris Thatcher to step down as President and CEO of Neuronetics

March 9, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Neuronetics, Inc and Chris Thatcher, the President and CEO, have mutually agreed that he will step down from his positions …
Appointment
what-is-pharmacovigilance-328154

The need for evolution in pharmacovigilance

March 9, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing feature, pharma, pharmacovigilance

Pharmacovigilance is a critical function in ensuring public health, but is our current system built to tackle the challenges of …
Feature
4420456374_64a3d7e6aa_75

Top Ten most popular articles on Pharmafile.com this week

March 6, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chinese Coronavirus, Wuhan Coronavirus, china coronavirus, coronavirus, wuhan coronavirus.

The coronavirus continues to threaten the global drug supply line, with disruption to the US drug production pipeline from the …
News
shutterstock

Scorpion venom added to CAR-T therapy increases efficacy in brain cancer, research shows

March 6, 2020 Medical Communications, Research and Development CAR-T, Cancer, brain cancer, glioblastoma, pharma

Chimeric antigen receptor T cell (CAR-T) therapy has gained much traction and attention in the past years for its innovative …
News
az_logo

Phase 3 failure for AstraZeneca’s Imfinzi combo in unresectable metastatic bladder cancer

March 6, 2020 Medical Communications, Research and Development AstraZeneca, Cancer, Imfinzi, bladder cancer, pharma, trial failure

New Phase 3 has been released by AstraZeneca, showing that the PD-L1 inhibitor Imfinzi (durvalumab), when combined with tremelimumab, failed …
News
shutterstock_138095450

New study calculates median drug development costs at circa $1 billion

March 5, 2020 Manufacturing and Production, Research and Development, Sales and Marketing drug development, drug prices, pharma

New research has pinned a concrete figure on the perennial industry question: how much does it cost to bring a …
News
takeda_logo_506_small

Positive CHMP approval for Takeda’s Alunbrig in ALK+ advanced non-small lung cancer

March 4, 2020 Research and Development CHMP, EMA, Takeda, lung cancer, pharma

Takeda’s Alunbrig (brigatinib) has been recommended for approval by the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human …
News
chart-trading-courses-forex-preview

Big Pharma more profitable than most public firms

March 4, 2020 Research and Development Big Pharma, US Pharma, drug prices, drug regulations, regulations

Large pharmaceutical companies make a much larger profit than most other public companies, according to a new study. The research …
News
diet-pills-medication-pharmacy-sick

India reducing API exports due to coronavirus threatening global supply chain

March 4, 2020 Research and Development APIs, Active Pharmaceuticals Ingredients, Big Pharma, Chinese Coronavirus, Wuhan Coronavirus, coronavirus

India is set to reduce exports of active pharmaceutical ingredients (APIs) until further notice, due to fears of internal drug …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025